Aelo

Aelo operates at the intersection of consumer wearables, digital health, wellness, and neurotechnology. Its proposed differentiation is not simply activity tracking: the product is intended to measure cognitive readiness in real time, surface live prefrontal-cortex signals, and summarize them through CoreScore. That positioning places Aelo alongside broader categories such as meditation technology, sleep and recovery wearables, biofeedback devices, and emerging brain-computer-interface products. The emphasis on a simple readiness score may help translate complex neural measurements into a consumer-oriented experience, while the wearable form factor could support continuous or situational use. At the same time, the proposition depends on the quality, repeatability, and interpretation of the underlying signals—areas for which supporting technical and clinical detail is limited. Aelo therefore appears to be an early-stage entrant defining a consumer neurotechnology category rather than an established market leader with demonstrated scale.

Aelo's visible trajectory is centered on moving from product concept toward consumer access. The company describes a brain wearable capable of real-time cognitive-readiness measurement, with live prefrontal-cortex signals and CoreScore as its core product elements. There are also no documented financing milestones to establish a capital-backed expansion curve. The main potential inflection point is therefore the transition from a website-described technology to a shipped, repeatedly used product with evidence of signal reliability and user retention. A second inflection point would be demonstrating that CoreScore supports actionable decisions rather than functioning only as a descriptive wellness metric. Until those milestones are documented, Aelo's growth should be characterized as pre-commercial or early commercialization-stage activity, with product definition clearer than operating scale. No layoffs are reported, but hiring activity is unknown.